Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Raeliva
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict71/ 100
Grade C · #140Raeliva
New telehealth brand selling compounded semaglutide and tirzepatide as shots or under-the-tongue tablets, at one price at every dose.
Visit RaelivaThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 71/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Raeliva still earns its place — shoppers who want mainstream telehealth GLP-1 access.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results75
92
Real-world results75
97Price honesty74
97
Price honesty74
96Prescriber access57
96
Prescriber access57
88Formulary choice88
88
Formulary choice88
95Cancellation fairness56
95
Cancellation fairness56
93Member support74
93
Member support74
Price, coverage & features
| Metric | CoreAge Rx | Raeliva |
|---|---|---|
| Verdict Score | 94/100 | 71/100 |
| Grade | A | C |
| Semaglutide | $99/mo | From $219/mo (month to month, all doses, compounded) |
| Tirzepatide | $149/mo | From $299/mo (month to month, all doses, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Raeliva
What we like
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
- Multiple administration formats
The caveats
- Three- and six-month plans are billed upfront
- A new brand with a short public track record
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Shoppers who want mainstream telehealth GLP-1 access.
Visit Raeliva Read the full Raeliva review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Raeliva does the reverse.
More on CoreAge Rx
More on Raeliva
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.